Cano ALE, Hernández ZC, Vega MME

Language: Spanish
References: 24
Page: 129-135
PDF size: 244.90 Kb.

ABSTRACT

The new beta coronavirus is a spherical shaped single-stranded RNA virus that projects protein spicules in a pattern similar to the solar corona observed by electron microscopy. This virus was named new coronavirus 2019 (2019 nCOV) by the World Health Organization (WHO) and was later termed SARS CoV-2 by the International Committee on Virus Taxonomy. It has a high human-to-human transmission rate and a reported mortality of 6.94% worldwide. The disease caused by this virus is COVID-19, currently it is recognized that it affects the respiratory, digestive, neurological and cutaneous systems.
The published evidence of primary skin manifestations related to SARS CoV-2 infection until April 29, 2020 was reviewed in the PubMed database. Varicella-like eruption and pseudochilblain are the dermatoses most associated with coronavirus infection and they are referred to as specific skin markers of the disease. Other dermatoses that have been associated with COVID-19 but are not considered specific to the same virus are disseminated maculopapular exanthem, urticaria, and livedo reticularis, among others. Until the last days of April, we have not found records of Mexican patients with skin involvement, so knowing the literature published around the world is of vital importance to identify potential skin markers that are diagnosed early or that occur during the course of the disease to try to reduce the spread of the virus or to know its behavior in the Mexican territory.

REFERENCES

1. Ng OT, Marimuthu K, Chia PY et al., sars cov-2 infection among travelers returning from Wuhan, China, N Engl J Med 2020, 12 de marzo, doi: 10.1056/NEJMc2003100.

2. Organización Mundial de la Salud, covid-19: cronología de la actuación de la oms. Disponible en: https://www.who.int/es/news-room/ detail/08-04-2020-who-timeline---CoVid-19.

3. Secretaría de Salud, Se confirma en México caso importado de coronavitus covid-19, Gobierno de México. Disponible en: https://www. gob.mx/salud/prensa/077-se-confirma-en-mexico-caso-importado- de-coronavirus-covid-19.

4. Recalcati S, Cutaneous manifestations in covid-19: a first perspective, J Eur Acad Dermatol Venereol 2020, 26 de marzo, doi: 10.1111/JDV.16387.

5. Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández Nieto D, Rodríguez-Villa Lario A et al., Classification of the cutaneous manifestations of covid-19: a rapid prospective nationwide consensus study in Spain with 375 cases, Br J Dermatol 2020, 29 de abril, doi: 10.1111/bjd.19163.

6. European Centre for Disease Prevention and Control, Case definition and European surveillance for covid-19, as of 2 March 2020, 2020. Disponible en: https://www.ecdc.europa.eu/en/case-definition- and-european-surveillance-humaninfection-novel-coronavirus- 2019-ncov.

7. Fernández-Nieto D, Ortega-Quijano D, Segurado-Miravalles G et al., Comment on: cutaneous manifestations in covid-19: a first perspective. Safety concerns of clinical images and skin biopsies, J Eur Acad Dermatol Venereol 2020, 15 de abril, doi: 10.1111/jdv.16470.

8. Marzano AV, Genovese G, Fabbrocini G et al., Varicella-like exanthem as a specific covid-19-associated skin manifestation: multicenter case series of 22 patients, J Am Acad Dermatol 2020, 16 de abril, S0190- 9622(20)30657-5.

9. Morey-Olivé M, Espiau M, Mercadal-Hally M et al., Manifestaciones cutáneas en contexto del brote actual de enfermedad por coronavirus 2019, An Pediatr 2020, 17 de abril, doi.org/doi:10.1016/j.anpedi. 2020.04.013.

10. Mahé A, Birckel E, Krieger S et al., A distinctive skin rash associated with coronavirus disease 2019?, J Eur Acad Dermatol Venereol 2020, 15 de abril, doi: 10.1111/JDV.16471.

11. Henry D, Ackerman M, Sancelme E et al., Urticarial eruption in covid- 19 infection, J Eur Acad Dermatol Venereol 2020, 15 de abril, doi: 10.1111/JDV.16472.

12. Alramthan A y Aldaraji W, A case of covid-19 presenting in clinical picture resembling chilblains disease. First report from the Middle East, Clin Exp Dermatol 2020, doi: 10.1111/ced.14243.

13. Kolivras A, Dehavay F, Delplace D et al., Coronavirus (covid-19) infection induced chilblains: a case report with histopathological findings, Am Acad Dermatol 2020, doi.org/10.1016/j.jdcr.2020.04.011.

14. Manalo IF, Smith MK, Cheeley J et al., A dermatologic manifestation of covid-19: transient livedo reticularis, J Am Acad Dermatol 2020, 10 de abril, S0190-9622(20)30558-2

15. Jiménez-Cauhe J, Ortega-Quijano D, Prieto-Barrios M et al., Reply to “covid-19 can present with a rash and be mistaken for dengue”: petechial rash in a patient with covid-19 infection, J Am Acad Dermatol 2020, 10 de abril, S0190-9622(20)30556-9.

16. Mazzotta F y Troccoli T, Monday’s case, Acute acro-ischemia in the child at the time of covid-19, doi.org/10.1016/j.anpedi.2020.04.013.

17. Estébanez A, Pérez-Santiago L, Silva E et al., Cutaneous manifestations in covid-19: a new contribution, J Eur Acad Dermatol Venereol 2020, 15 de abril, doi: 10.1111/jdv.16474.

18. Joob B y Wiwanitkit V, covid-19 can present with a rash and be mistaken for dengue, J Am Acad Dermatol 2020, mayo;82(5):e177.

19. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J et al., A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet 2020, 15 de febrero; 395(10223):514-52.

20. Yuen KS, Ye ZW, Fung SY, Chan CP y Jin DY, sars-cov-2 and covid- 19: the most important research questions, Cell Biosci 2020; 10:40.

21. Jin Y, Yang H, Ji W et al., Virology, epidemiology, pathogenesis, and control of covid-19, Viruses 2020, 27 de marzo; 12(4):E372.

22. covid-19 coronavirus pandemic. Disponible en: https://www.worldometers. info/coronavirus/.

23. Gobierno de México, Coronavirus. Disponible en: chttps://coronavirus. gob.mx.

24. Mungmungpuntipantip R y Wiwanitkit V, covid-19 and cutaneous manifestations, J Eur Acad Dermatol Venereol 2020, 15 de abril, doi: 10.1111/JDV.16483.